1,515 results on '"Krüger, Rejko"'
Search Results
2. Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
3. Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism
4. Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
5. Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome
6. Multiomics analysis identifies novel facilitators of human dopaminergic neuron differentiation
7. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes
8. Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
9. Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
10. Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
11. Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females
12. Comparison of two protocols for the generation of iPSC-derived human astrocytes
13. Impaired neuron differentiation in GBA-associated Parkinson’s disease is linked to cell cycle defects in organoids
14. Correction: Machine learning for predicting neurodegenerative diseases in the general older population: a cohort study
15. Machine learning for predicting neurodegenerative diseases in the general older population: a cohort study
16. Altered infective competence of the human gut microbiome in COVID-19
17. Aus- und Weiterbildung der Parkinsonpflege verbessern
18. Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson's disease
19. Determinants of patient-reported functional mobility in people with Parkinson's disease: A systematic review
20. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
21. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study
22. Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease
23. GBA-associated PD: chances and obstacles for targeted treatment strategies
24. Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
25. PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing
26. Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data
27. GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton
28. Genetically stratified Parkinson's disease with freezing of gait is related to specific pattern of cognitive impairment and non-motor dominant endophenotype.
29. Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire
30. Sensor-Based Quantification of MDS-UPDRS III Subitems in Parkinson’s Disease Using Machine Learning
31. The evolution and social determinants of mental health during the first wave of the COVID-19 outbreak in Luxembourg
32. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
33. Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson’s disease over time: A comparative analysis.
34. Human Dopaminergic Neurons Lacking PINK1 Exhibit Disrupted Dopamine Metabolism Related to Vitamin B6 Co-Factors
35. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression
36. Polygenic Risk Scores Validated in Patient‐Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
37. A Novel PINK1 p.F385S Loss‐of‐Function Mutation in an Indian Family with Parkinson's Disease.
38. DJ‐1 depletion prevents immunoaging in T‐cell compartments
39. Park7deletion leads to age- and sex-specific transcriptome changes involving NRF2-CYP1B1 axis in mouse midbrain astrocytes
40. Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson’s disease over time: A comparative analysis.
41. Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg
42. Retrograde procedural memory is impaired in people with Parkinson’s disease with freezing of gait
43. Education as Risk Factor of Mild Cognitive Impairment ‐ the Role of the Gut Microbiome
44. Analysis and visualisation of tremor dynamics in deep brain stimulation patients
45. A rule-based expert system for real-time feedback-control in deep brain stimulation
46. Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
47. Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
48. PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
49. Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening
50. Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.